Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Adrian R. Krainer

Director at Stoke Therapeutics, Inc. (STOK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.9M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 12SEC STOKStoke Therapeutics, Inc. Sell Plan 33,243283,302 held (−11%) $39.74 $1.3M -37.7%
Mar 4SEC STOKStoke Therapeutics, Inc. Sell Plan 7,229316,545 held (−2%) $39.66 $287K -37.6%
Nov 26SEC STOKStoke Therapeutics, Inc. Sell Plan 40,472323,774 held (−11%) $29.72 $1.2M -16.8%
Nov 18SEC STOKStoke Therapeutics, Inc. Sell Plan 19,790384,928 held (−5%) $26.61 $527K -7.0%
Nov 18SEC STOKStoke Therapeutics, Inc. Sell Plan 20,682364,246 held (−5%) $27.34 $565K -9.5%
  • Sell

    Director Adrian R. Krainer sold $1.3M of STOK at $39.74 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adrian R. Krainer sold $287K of STOK at $39.66 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adrian R. Krainer sold $1.2M of STOK at $29.72 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adrian R. Krainer sold $527K of STOK at $26.61 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Adrian R. Krainer sold $565K of STOK at $27.34 — pre-scheduled 10b5-1 plan sale.